AI and Machine Learning – Changing the Health Care Landscape

But Don’t Exclude Sterile Processing from Key Discussions By David Taylor, MSN, RN, CNOR Ancient papyrus revealed Egyptian medical practice was highly advanced and doctors performed the first surgery more than 3,500 years ago (2750 BC).[1, 2] Since then, medicine has...

The Concept of Modular Credentials

By James X. Stobinski, PhD, RN, CNOR, CSSM (E) Recently, during the question and answer period following a presentation, I was asked how the Competency and Credentialing Institute (CCI) is evolving in response to the COVID-19 pandemic. The context for this question...

Reopening to the New Normal

By Bill Prentice From early March through the end of April, it seemed that almost everyone I talked to used the word “coronavirus” or “COVID-19” at some point in our conversation. ASCA staff worked seven days a week during that time, conferring with federal and state...

Why Air Disinfection Systems are Becoming an Increasingly Vital Component of Patient Care

Sponsored by Avante Health Solutions By Brent Kramer Medical facilities are incorporating air filtration systems to help safeguard patients and staff from coronavirus transmission. As coronavirus restrictions ease across the United States, medical facilities are...

Mölnlycke acquires patent for smart solutions to detect infection in wounds

The Swedish medical solutions company, Mölnlycke, is acquiring a patent from Innovation Skåne, that will help detect infections in wounds. Once developed, the patent will play a major role in reducing the unnecessary use of antibiotics in wound care.

The incidence of infection in hard-to-heal chronic wounds, such as diabetic foot ulcers and venous leg ulcers, is high – and one in 20 patients undergoing surgery will develop a surgical site infection [1]. However, infected wounds are costly, difficult to manage and hard to detect. In many cases, expensive antimicrobials are used prophylactically to prevent infections or to treat them once they have been established.

Mölnlycke has agreed to acquire the patent from Swedish regional innovation company, Innovation Skåne. This technology can detect infections and alert caregivers that the wound needs attention. It will help to minimise the prophylactic use of antibiotics and reduce the risk of complications related to infections.

Barry McBride, Executive Vice President R&D said: “Antimicrobial resistance is an increasingly significant threat to public health worldwide. This exciting new technology will help reduce the incidence of serious infection and minimise the unnecessary use of antibiotics.”

Joakim Nelson, CEO of Innovation Skåne, said: “This is an example of innovations originating from employees in Region Skåne and demands in their daily work. We share Mölnlycke’s goal of driving innovative improvements in healthcare and we are delighted Mölnlycke will be able to use this patent to help tackle a serious public healthcare issue.”



Submit a Comment

Your email address will not be published. Required fields are marked *